Literature DB >> 11857421

Photodynamic therapy with hypericin induces vascular damage and apoptosis in the RIF-1 mouse tumor model.

Bin Chen1, Tania Roskams, Yan Xu, Patrizia Agostinis, Peter A M de Witte.   

Abstract

Hypericin, a polycyclic quinone obtained from plants of the genus Hypericum, has been proven to be a potent photosensitizer. The mechanism of tumor eradication and mode of cell death induced by in vivo photodynamic therapy (PDT) with hypericin were investigated in the present study using 2 therapeutic protocols. RIF-1 tumors were exposed to laser light at either 0.5 hr or 6 hr after hypericin administration (5 mg/kg, i.v.). A significant reduction in tumor perfusion, as determined by the retention of fluorescein in the tumor tissue, was detected immediately after both PDT treatments. Further decrease in tumor perfusion was observed in the hours after treatment. The re-establishment of tumor perfusion, however, occurred 24 hr after 6 hr-interval PDT, but not after 0.5 hr-interval PDT. The kinetics of tumor cell survival estimated by the in vivo/in vitro clonogenic assay revealed no or limited cell death when tumors were explanted immediately after irradiation, whereas a delayed but progressive cell death was detected when tumors remained in situ after both PDT treatments. The detection of nucleosomal DNA fragmentation by agarose gel electrophoresis or TUNEL assay and the assessment of cell morphology by light microscopy indicated that apoptosis was the most prominent tumor response to hypericin-mediated PDT. Furthermore, immunohistochemical analysis of the tumor tissue showed an increased expression of both Fas and Fas ligand after irradiation, suggesting that this cell death pathway might contribute to the overall PDT-induced apoptotic response. In conclusion, our results demonstrate that apoptosis, likely occurring as a result of vascular damage, is responsible for the tumor eradication by PDT with hypericin in this tumor model. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11857421     DOI: 10.1002/ijc.10175

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  16 in total

Review 1.  Photodynamic therapy and anti-tumour immunity.

Authors:  Ana P Castano; Pawel Mroz; Michael R Hamblin
Journal:  Nat Rev Cancer       Date:  2006-07       Impact factor: 60.716

2.  Epigenetically Enhanced PDT Induces Significantly Higher Levels of Multiple Extrinsic Pathway Apoptotic Factors than Standard PDT, Resulting in Greater Extrinsic and Overall Apoptosis of Cutaneous T-cell Lymphoma.

Authors:  Katrin A Salva; Youn H Kim; Ziba Rahbar; Gary S Wood
Journal:  Photochem Photobiol       Date:  2018-05-20       Impact factor: 3.421

3.  Spatiotemporal autophagic degradation of oxidatively damaged organelles after photodynamic stress is amplified by mitochondrial reactive oxygen species.

Authors:  Noemí Rubio; Isabelle Coupienne; Emmanuel Di Valentin; Ingeborg Heirman; Johan Grooten; Jacques Piette; Patrizia Agostinis
Journal:  Autophagy       Date:  2012-08-14       Impact factor: 16.016

4.  Epigenetically Enhanced Photodynamic Therapy (ePDT) is Superior to Conventional Photodynamic Therapy for Inducing Apoptosis in Cutaneous T-Cell Lymphoma.

Authors:  Katrin Agnes Salva; Gary S Wood
Journal:  Photochem Photobiol       Date:  2015-10-12       Impact factor: 3.421

5.  Proteasome inhibition potentiates antitumor effects of photodynamic therapy in mice through induction of endoplasmic reticulum stress and unfolded protein response.

Authors:  Angelika Szokalska; Marcin Makowski; Dominika Nowis; Grzegorz M Wilczynski; Marek Kujawa; Cezary Wójcik; Izabela Mlynarczuk-Bialy; Pawel Salwa; Jacek Bil; Sylwia Janowska; Patrizia Agostinis; Tom Verfaillie; Marek Bugajski; Jan Gietka; Tadeusz Issat; Eliza Glodkowska; Piotr Mrówka; Tomasz Stoklosa; Michael R Hamblin; Pawel Mróz; Marek Jakóbisiak; Jakub Golab
Journal:  Cancer Res       Date:  2009-05-12       Impact factor: 12.701

6.  Hypericin-mediated photodynamic therapy of pituitary tumors: preclinical study in a GH4C1 rat tumor model.

Authors:  Chad D Cole; James K Liu; Xiaoming Sheng; Steven S Chin; Meic H Schmidt; Martin H Weiss; William T Couldwell
Journal:  J Neurooncol       Date:  2008-01-29       Impact factor: 4.130

7.  Elucidation of the tumoritropic principle of hypericin.

Authors:  M Van de Putte; T Roskams; J R Vandenheede; P Agostinis; P A M de Witte
Journal:  Br J Cancer       Date:  2005-04-25       Impact factor: 7.640

Review 8.  Photodynamic Therapy-Current Limitations and Novel Approaches.

Authors:  Gurcan Gunaydin; M Emre Gedik; Seylan Ayan
Journal:  Front Chem       Date:  2021-06-10       Impact factor: 5.221

9.  Molecular profiling of angiogenesis in hypericin mediated photodynamic therapy.

Authors:  Ramaswamy Bhuvaneswari; Yik Y Gan; Sasidharan S Lucky; William W L Chin; Seyed M Ali; Khee C Soo; Malini Olivo
Journal:  Mol Cancer       Date:  2008-06-13       Impact factor: 27.401

10.  Hypericin-mediated photodynamic therapy induces apoptosis in K562 human leukemia cells through JNK pathway modulation.

Authors:  Yixiao Xu; Dexuan Wang; Zhizhi Zhuang; Keke Jin; Lvzhen Zheng; Qing Yang; Kunyuan Guo
Journal:  Mol Med Rep       Date:  2015-08-27       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.